partners could realistically come from Europe to launch Ryoncil there… IBD/Crohns data is amazing and it’s been strangely quiet on that front, almost like they are in exclusive due diligence or something… label extension is for the taking given Ryoncil now approved..
and of course heart partner … surely one of these will be announced before the end of the calendar year! Should be a good lead up to Xmas once more!
MSB Price at posting:
$1.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)